Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial

OBJECTIVE Postbariatric hypoglycemia affects >50% of individuals who have undergone Roux-en-Y gastric bypass surgery. Despite the often debilitating nature of this complication, existing treatment options are limited and often inefficient. Dasiglucagon is a stable glucagon analog available in a r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes care 2023-12, Vol.46 (12), p.2208-2217
Hauptverfasser:	Nielsen, Casper K., Øhrstrøm, Caroline C., Houji, Inas J.K., Helsted, Mads M., Krogh, Liva S.L., Johansen, Nicklas J., Hartmann, Bolette, Holst, Jens J., Vilsbøll, Tina, Knop, Filip K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials Gastric bypass Gastrointestinal surgery Glucagon Glucose Health services Hypoglycemia Obesity Placebos Research design Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!